Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
O
← Scanner

TMOThermo Fisher Scientific Inc.

Healthcare·Diagnostics & Research·NYSE·Mkt cap $220.00B
$528.69
$1.74 (+0.33%) today
IEX feed · not consolidated
Last updated Jul 14, 10:09 AM
67/100 Opportunity
31Risk
80Momentum
84Pullback
75Quality
68Valuation
58Trend
Price & History (up to 5 years)
2025-09-11 → 2026-09-11
Low 437.71— support · — resistanceHigh 638.02
Technical Indicators
RSI (14)65.5
MACD hist2.61
ATR (14)13.86
SMA 20497.72
SMA 50478.49
SMA 200526.87
Rel volume0.6x
Boll upper544.84
Boll lower450.60
52w high642.43
52w low402.22
5y high663.43
5y low384.37
Hist. vol31%
Max drawdown-31%
Sideways RangeStrong Momentum WatchHigh-Quality PullbackEntry: Pullback Watch
Company QualityHigh Quality
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Thermo Fisher Scientific Inc. — Diagnostics & Research company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
High-Quality Pullback Watch
Opportunity Score
67/100
Risk Level
Low-Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: TMO is trading near recent levels (+0.3% today). Overall, the company is fundamentally strong. It is in a longer-term sideways range. The recent drop appears more connected to normal volatility than company-specific failure, and price is approaching a historical support zone. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality75
Historical Context50
Valuation68
Trend58
Momentum80
Pullback84
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward85
Entry Timing55
Sell Risk20
Risk31

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent NewsLive headlines

Real headlines from across the web. By default Olmem reads them with its rule-based news engine (keyword-classified — no AI) to set the News Sentiment score. Connect your own AI provider to have it read these actual headlines in the AI Stock Explanation.